- Home
- SILO vs EKSO Comparison
SILO vs EKSO Comparison
Compare SILO & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- EKSO
- Stock Information
- Founded
- SILO 2010
- EKSO 2005
- Country
- SILO United States
- EKSO United States
- Employees
- SILO N/A
- EKSO N/A
- Industry
- SILO Apparel
- EKSO Medical/Dental Instruments
- Sector
- SILO Consumer Discretionary
- EKSO Health Care
- Exchange
- SILO Nasdaq
- EKSO Nasdaq
- Market Cap
- SILO 8.0M
- EKSO 7.7M
- IPO Year
- SILO N/A
- EKSO N/A
- Fundamental
- Price
- SILO $0.43
- EKSO $4.32
- Analyst Decision
- SILO
- EKSO Strong Buy
- Analyst Count
- SILO 0
- EKSO 2
- Target Price
- SILO N/A
- EKSO $7.75
- AVG Volume (30 Days)
- SILO 275.0K
- EKSO 50.0K
- Earning Date
- SILO 11-13-2025
- EKSO 10-28-2025
- Dividend Yield
- SILO N/A
- EKSO N/A
- EPS Growth
- SILO N/A
- EKSO N/A
- EPS
- SILO N/A
- EKSO N/A
- Revenue
- SILO $72,102.00
- EKSO $14,749,000.00
- Revenue This Year
- SILO $1.86
- EKSO N/A
- Revenue Next Year
- SILO N/A
- EKSO $49.96
- P/E Ratio
- SILO N/A
- EKSO N/A
- Revenue Growth
- SILO N/A
- EKSO N/A
- 52 Week Low
- SILO $0.36
- EKSO $2.73
- 52 Week High
- SILO $3.37
- EKSO $14.97
- Technical
- Relative Strength Index (RSI)
- SILO 38.57
- EKSO 42.62
- Support Level
- SILO $0.39
- EKSO $3.86
- Resistance Level
- SILO $0.43
- EKSO $4.32
- Average True Range (ATR)
- SILO 0.04
- EKSO 0.40
- MACD
- SILO -0.00
- EKSO -0.11
- Stochastic Oscillator
- SILO 39.29
- EKSO 21.58
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.